Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
January 30 2023 - 4:05PM
Business Wire
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the
"Company"), a wearable medical robotics company that offers
increased functionality for those suffering from neurological
disorders and upper-limb paralysis, today announced the appointment
of Yitzchak Jacobovitz as a Class II director effective January 27,
2023, to serve until the 2025 annual meeting of stockholders. With
this appointment, Myomo has six directors.
Mr. Jacobovitz, 47, is currently a partner and lead healthcare
analyst at AIGH Capital Management and affiliates (“AIGH”), where
he has significantly grown AIGH’s healthcare footprint since
joining in 2014. Prior to AIGH, Mr. Jacobovitz was a managing
director at Capstone, a policy research firm and an analyst at Leap
Tide Capital, a special situations hedge fund. Mr. Jacobovitz
earned his Masters in Business Administration from Johns Hopkins
University and is a Chartered Financial Analyst
“We welcome Yitz to the Myomo Board of Directors and are
gratified that AIGH was the lead investor in our most recent equity
offering,” said Paul R. Gudonis, Chairman and Chief Executive
Officer of Myomo. "Yitz brings extensive healthcare investment
experience to our board and we look forward to his contributions as
we build value for our stockholders."
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers
improved arm and hand function for those suffering from
neurological disorders and upper-limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper-limb
orthosis designed to support the arm and restore function to the
weakened or paralyzed arms of certain patients suffering from CVA
stroke, brachial plexus injury, traumatic brain or spinal cord
injury, ALS or other neuromuscular disease or injury. It is
currently the only marketed device that, sensing a patient’s own
EMG signals through non-invasive sensors on the arm, can restore an
individual’s ability to perform activities of daily living,
including feeding themselves, carrying objects and doing household
tasks. Many are able to return to work, live independently and
reduce their cost of care. Myomo is headquartered in Boston,
Massachusetts, with sales and clinical professionals across the
U.S. and representatives internationally. For more information,
please visit www.myomo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230130005609/en/
For Myomo: ir@myomo.com
Investor Relations: Kim Sutton Golodetz LHA Investor
Relations 212-838-3777 kgolodetz@lhai.com
Myomo (AMEX:MYO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Myomo (AMEX:MYO)
Historical Stock Chart
From Sep 2023 to Sep 2024